Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Levodopa

Authors

  • Kapde Ghrushneshwar University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar
  • Wakte Pravin University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar
  • Bhusari Sachin University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

DOI:

https://doi.org/10.22270/ajprd.v13i4.1609

Abstract

Aim: The aim of the proposed study was to development and validation of simple, accurate, precise yet economical UV-Visible spectrophotometric method for the quantitative estimation of Levodopa.

Methods: A UV–Visible spectrophotometric method was developed using a co-solvent system consisting of 20% methanol and 80% 0.01M potassium hydrogen phosphate buffer (K₂HPO₄). Levodopa solution was scanned over the entire UV-visible range to determine its wave length of maximum absorbance. The method was validated in accordance with the ICH Q2(R1) guidelines which involves various parameters viz. linearity, accuracy, precision, robustness, ruggedness, limit of detection (LOD), and limit of quantitation (LOQ).

Results: The wavelength of maximum absorbance (λmax) for Levodopa was observed at 283 nm using a co-solvent system composed of 20% methanol and 80% 0.01M potassium phosphate buffer (K₂HPO₄).The developed UV–Visible spectrophotometric method demonstrated excellent linearity across the concentration range of 5 to 60μg/mL, with a correlation coefficient (r²) of 0.999. The intra-day accuracy in terms of % Differencewas in the range of −7.88% to +4.46% and Inter day accuracy was in the range of −7.60% to +2.42%. The precision values(% RSD) were found to be below 3% for both intra- and inter-day studies. Robustness and ruggedness studies confirmed the method’s reliability under deliberate variations in analytical conditions with %RSD values below 3%. The limit of detection (LOD) and limit of quantitation (LOQ) were determined to be 0.9189μg/mL and 2.7884μg/mL, respectively, ensuring adequate sensitivity for routine quality control analysis.

Conclusion: A simple, accurate, precise and cost-effective UV-visible spectrophotometric method was successfully developed for the estimation of Levodopa. The method was developed using an economical percentage of the organic phase in co-solvent system. The validated UV-Visible method was found to be efficient for the estimation of Levodopa in the commercial samples. Considering the advantages, said developed method can be used for the routine analysis of Levodopa.

 

Downloads

Download data is not yet available.

Author Biographies

Kapde Ghrushneshwar, University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

Wakte Pravin, University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

Bhusari Sachin, University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

University Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Chhatrapati Sambhajinagar

References

Analytical method development for simultaneous estimation for drug content and release of levodopa, Carbidopa and Entacapone in combined dosage form by rp-HPLC. The Pharma Innovation Journal [Internet]. 2018;7(8):60–72. Available from: www.thepharmajournal.com

Tehrani B. Development and Validation of a Derivative Spectrophotometric Method for Simultaneous Multicomponent Determination of Levodopa, Carbidopa and Entacapone. Vol. 42, J. Chem. Chem. Eng. Research Article. 2023.

Elbashir A, Aboul-Enein HY, Elshiekh B, Basheir A, Elbashir AA. Development and validation of spectrophotometric method for the determination of levodopa (L-dopa) in pharmaceutical formulations [Internet]. Vol. 60, Rev. Roum. Chim. 2015. Available from: http://web.icf.ro/rrch/

Neha SL, Pannu A, Sahoo PK. Development and Validation of UV Spectroscopic Technique for the Assessment of Dopamine to Prepare NLC Formulation in the Therapy of Parkinson’s Disease. Analytical Chemistry Letters. 2021;11(4):553–62.

BULDUK İ, TOPAL N. Development and Validation of a Quantification Method for L-DOPA in Plants and Pharmaceutical Materials. Hacettepe Journal of Biology and Chemistry. 2021 Jan 1;49(1):1–10.

Pereira RL, Paim CS, Barth AB, Raffin RP, Guterres SS, Schapoval EES. Levodopa microparticles for pulmonary delivery: Photodegradation kinetics and LC stability-indicating method. Pharmazie. 2012;67(7):605–10.

Tesoro C, Ciriello R, Lelario F, Di Capua A, Pascale R, Bianco G, et al. Development and Validation of a Reversed-Phase HPLC Method with UV Detection for the Determination of L-Dopa in Vicia faba L. Broad Beans. Molecules. 2022 Nov 1;27(21).

Akbel E, Bulduk İ. Development and Validation of Analytical Methods for Quantification of L-Dopa; Application to Plant Materials. International Journal of Innovative Approaches in Agricultural Research [Internet]. 2023 Jun 29;7(2):208–19. Available from: http://ijiaar.penpublishing.net/makale/3860.

Nagaraja P, Srinivasa Murthy KC, Rangappa KS, Made Gowda NM. Spectrophotometric methods for the determination of certain catecholamine derivatives in pharmaceutical preparations. Vol. 46, Talanta. 1998.

Krisai K, Charnvanich D, Chongcharoen W. Increasing the solubility of levodopa and carbidopa using ionization approach [Internet]. Vol. 2020, TJPS. Available from: http://www.tjps.pharm.chula.ac.th

Freitas ME, Ruiz-Lopez M, Fox SH. Novel Levodopa Formulations for Parkinson’s Disease. Vol. 30, CNS Drugs. Springer International Publishing; 2016. p. 1079–95.

Haddad F, Sawalha M, Khawaja Y, Najjar A, Karaman R. Dopamine and levodopa prodrugs for the treatment of Parkinson’s disease. Vol. 23, Molecules. MDPI AG; 2018.

Ahmad MZ, Sabri AH Bin, Anjani QK, Domínguez-Robles J, Abdul Latip N, Hamid KA. Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery. Pharmaceuticals. 2022 Mar 1;15(3).

Published

2025-08-30 — Updated on 2025-08-15

Versions

How to Cite

Kapde Ghrushneshwar, Wakte Pravin, & Bhusari Sachin. (2025). Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Levodopa . Asian Journal of Pharmaceutical Research and Development, 13(4), 166–172. https://doi.org/10.22270/ajprd.v13i4.1609 (Original work published August 30, 2025)